Evidence map›Paper›PMID 35673907›Full record

Trial reportNan fang yi ke da xue xue bao = Journal of Southern Medical University2022

[

Y Cui, J Mi, Y Feng, L Li, Y Wang, J Hu, H Wang

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Advancement ofChinese herbal medicines · 2026
    Review
  3. Article
  4. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Bioactive Compounds inNutrients · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Traditional Chinese Medicine for Breast Cancer: A Review.Breast cancer (Dove Medical Press) · 2023
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Y CuiDepartment of Traditional Chinese Medicine, General Hospital of Chinese PLA, Beijing 100853, China.
J MiDepartment of General Practice, Zhanjiang Central People's Hospital, Zhanjiang 524045, China.
Y FengDepartment of Traditional Chinese Medicine, General Hospital of Chinese PLA, Beijing 100853, China.
L LiDepartment of Traditional Chinese Medicine, General Hospital of Chinese PLA, Beijing 100853, China.
Y WangDepartment of Traditional Chinese Medicine, General Hospital of Chinese PLA, Beijing 100853, China.
J HuDepartment of Traditional Chinese Medicine, General Hospital of Chinese PLA, Beijing 100853, China.
H WangDepartment of Traditional Chinese Medicine, General Hospital of Chinese PLA, Beijing 100853, China.
Chinese PLA General Hospital · CNCentral People's Hospital of Zhanjiang · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the clinical efficacy of

methodsA total of 94 breast cancer patients who developed CRF of spleen and stomach Qi deficiency type after chemotherapy were randomized into chemotherapy group (

resultsThe scores for somatic fatigue, emotional fatigue and cognitive fatigue, along with the overall fatigue score, showed more significant improvements in TCM+chemotherapy group than in chemotherapy group (

conclusionHQSJZD can obviously improve CRF symptoms in breast cancer patients possibly by regulating multiple signaling pathways including PI3K-Akt through AKT1.

Indexed as

Breast NeoplasmsDrugs, Chinese HerbalFemaleHumansMedicine, Chinese TraditionalMolecular Docking SimulationNetwork PharmacologyPhosphatidylinositol 3-KinasesDrugs, Chinese HerbalPhosphatidylinositol 3-KinasesSijunzi decoctionbreast cancer chemotherapycancer-related fatigueHuangqi Sijunzi decoctionmolecular dockingnetwork pharmacology

Identifiers

PMID35673907
PMCPMC9178628
OpenAlexW4282946259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.